McClaskey James Paul
- SEC CIK
- 0001920558
No open-market purchases or sales filed in the past year.
Current role at each company
- INSG Inseego Corp.Chief Accounting Officeras of Jul 16, 2026
- CELL Bruker Cellular Analysis, Inc.SVP, Chief Accounting Officeras of May 23, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists McClaskey James Paul as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CELL Bruker Cellular Analysis, Inc.
SVP, Chief Accounting Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 24, 2022 (view filing) | Oct 20 | 4 days | McClaskey James PaulSVP, Chief Accounting Officer | SSale | −122 | $1.99 | −$242.78 | −0.2%67.2K after |